Cancer Immunotherapy


ABL Bio's immuno-oncology strategy


T cell Engager 4-1BB BsAb & Competitive Landscape

Screenshot 2018-12-18 08.47.30.png

Anti-Tumor Effect without Liver Toxicity by T cell Engager 4-1BB BsAb

anti tumor effect.jpg

Recent Immuno-Oncology Deals: “Early-stage & Bigger Deals”

Screenshot 2018-12-18 08.57.53.png